Online Program Home
My Program
All Times EDT
Legend:
* = applied session ! = JSM meeting theme
Activity Details
|
|
|
|
164 * !
|
Tue, 8/4/2020,
10:00 AM -
11:50 AM
|
Virtual
|
|
Leveraging Real-World Data in the Drug Development Process — Topic Contributed Papers
|
|
Biopharmaceutical Section, Biometrics Section, Health Policy Statistics Section
|
|
Organizer(s): Rebecca A Hubbard, University of Pennsylvania
|
|
Chair(s): Nandita Mitra, University of Pennsylvania
|
|
10:05 AM
|
Hybrid Controlled Trials with EHR-Derived Data for Cancer Trials: What, Why, When, and How
Brian Segal, Flatiron Health; Melissa Curtis, Flatiron Health; Meghna Samant, Flatiron Health; Katherine Tan, Flatiron Health; Shrujal Baxi, Flatiron Health; Somnath Sarkar, Flatiron, Inc.
|
|
10:25 AM
|
Data-Adaptive Weighting of Real-World and Randomized Controls Using Propensity Scores
Joanna Harton, University of Pennsylvania; Nandita Mitra, University of Pennsylvania; Rebecca A Hubbard, University of Pennsylvania
|
|
10:45 AM
|
Leveraging RWD and Historical Data in Design and Analysis of Clinical Trials
Samson Ghebremariam, Novartis Pharmaceuticals; Lisa Hampson, Novartis Pharmaceuticals; Bharani Bharani-Dharan, Novartis Oncology; Amy Racine-Poon, Novartis Pharma AG; Beat Neuenschwander, Novartis pharmaceuticals
|
|
11:05 AM
|
Calibrated Survival Curve and Treatment Comparison with Imperfect Survival Outcomes from Electronic Health Records
Chuan Hong, Harvard Medical School; Liang Liang, Harvard T. H. Chan School of Public Health; Tianxi Cai, Harvard University
|
|
11:25 AM
|
Discussant: Elizabeth Teeple, US Food and Drug Administration
|
|
11:45 AM
|
Floor Discussion
|
|
